MRC CTU at UCL research at the 9th IAS Conference on HIV Science and International HIV Paediatrics Workshop
21 Jul 2017
HIV researchers from around the world will be meeting in Paris over the next few days to share their latest research findings at the 9th IAS Conference on HIV Science, and the International HIV Paediatrics Workshop. There will be a number of presentations from MRC CTU at UCL, and our collaborators. Details can be found in the table below.
|
Day |
Presenter |
Title |
Session details |
Abstract number |
|
21 July |
Lizzie Chappell |
The cascade of care for children with HIV in the UK and Ireland in 2015 |
12:15-14:00, Poster viewing |
Poster #58 |
|
21 July |
Anna Turkova |
Use and safety of tenofovir disoproxil fumarate (TDF) in children and adolescents with HIV in paediatric cohorts in the European Union |
12:15-14:00, Poster viewing |
Poster #30 |
|
21 July |
Alex Lyons |
Safety of Etravirine (ETR) in young people with HIV: Patient characteristics, adverse events and discontinuation |
12:15-14:00, Poster viewing |
Poster #35 |
|
21 July |
Ruth Goodall |
Incidence of virological failure to first-line ART among children in Europe and Thailand |
11:45-12:00, Oral Abstract Presentations session |
Paper Number 5 |
|
21 July |
Ruth Goodall |
CD4 recovery following antiretroviral treatment interruptions in HIV-positive children and adolescents in Europe and Thailand |
12:15-14:00, Poster viewing |
Paper Number 51 |
|
22 July |
Ali Judd |
Experiences of transition to adult care and readiness to self-manage care in young people with perinatal HIV in England |
14:45-15:00, Oral Abstract Presentations session |
Paper Number 20 |
|
23 July |
Sheena McCormack |
After PROUD… |
12:30-14:30, Bordeaux Ampitheatre |
Non-Commercial Satellite |
|
24 July |
Francois Raffi |
Patient reported outcomes (PROs) in HIV-infected adults enrolled in the NEAT001/ANRS143 trial comparing first-line ART regimens with darunavir/ritonavir (DRV/r) in combination with tenofovir DF/emtricitabine (TDF/FTC) or raltegravir (RAL) |
12:30-14:30, Poster Exhibition area |
MOPEB0286 |
|
24 July |
Sheena McCormack |
Adding D to the ABC: putting the drugs in the ABC of prevention |
08:45-10:30, Le Grand Ampitheatre |
Plenary |
|
25 July |
Sheena McCormack |
Long-term follow-up of PROUD: evidence for high continued HIV exposure and durable effectiveness of PrEP |
11:00-12:30, Blue Ampitheater |
TUAC0101 |
|
25 July |
Mitzy Gafos |
Experiences and perceptions of PrEP among gay and other men who sex with men (MSM) using PrEP in the PROUD study in England |
11:00-12:30, Blue Ampitheater |
TUAC0105 |
|
26 July |
Anna Turkova |